Rezolute (RZLT) Common Equity (2010 - 2026)
Rezolute (RZLT) reported Common Equity of $116.8 million for Q1 2026, up 41.5% on a YoY basis from $82.6 million in Q1 2025, and down 8.72% sequentially from $128.0 million in Q4 2025.
Rezolute (RZLT) Common Equity (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 17 years of Common Equity data on file, last reported at $116.8 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 41.5% year-over-year to $116.8 million; the trailing twelve-month figure through Mar 2026 stood at $116.8 million (up 41.5% YoY), and the FY2025 full-year result was $162.1 million, up 33.99% from the prior year.
- Common Equity slipped to $116.8 million in Q1 2026, from $128.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $162.1 million in Q2 2025 to a low of $51.9 million in Q1 2022.
- A 5-year average of $116.2 million and a median of $116.8 million in 2026 frame the typical range for Common Equity.
- Across the five-year window, Common Equity jumped 610.1% in 2022 and sank 44.34% in 2024, its largest moves.
- Tracing RZLT's Common Equity over 5 years: stood at $141.3 million in 2022, then sank by 35.07% to $91.7 million in 2023, then rose by 8.57% to $99.6 million in 2024, then advanced by 28.53% to $128.0 million in 2025, then slipped by 8.72% to $116.8 million in 2026.
- Business Quant data shows RZLT's Common Equity at $116.8 million in Q1 2026, $128.0 million in Q4 2025, and $147.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | 116.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.83 Mn |
| Dec 31, 2025 | 128.00 Mn |
| Sep 30, 2025 | 147.17 Mn |
| Jun 30, 2025 | 162.13 Mn |
| Mar 31, 2025 | 82.57 Mn |
| Dec 31, 2024 | 99.59 Mn |
| Sep 30, 2024 | 113.44 Mn |
| Jun 30, 2024 | 121.00 Mn |
| Mar 31, 2024 | 70.86 Mn |
| Dec 31, 2023 | 91.73 Mn |
| Sep 30, 2023 | 103.56 Mn |
| Jun 30, 2023 | 116.17 Mn |
| Mar 31, 2023 | 127.32 Mn |
| Dec 31, 2022 | 141.27 Mn |
| Sep 30, 2022 | 153.09 Mn |
| Jun 30, 2022 | 149.47 Mn |
| Mar 31, 2022 | 51.91 Mn |
| Dec 31, 2021 | 62.27 Mn |
| Sep 30, 2021 | 21.56 Mn |
| Jun 30, 2021 | 26.10 Mn |